Teladoc Health's stock has declined since its pandemic peak, with disappointing financial results. Despite challenges, factors like a large ecosystem and growth opportunities could help it recover under new CEO Charles Divita. However, risks remain due to past financial issues and tough competition.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing